McDonald 2013.
Study characteristics | ||
Study design | Cohort | |
Study setting | Setting: Royal North Shore Hospital and the North Shore Private Hospital, Sydney Country: Australia Dates: NR |
|
Selection of participants | Retrospective cohort of people with primary GBM treated by gross total resection | |
Participant characteristics | Sample size: 78 (deaths: 74) Age: mean 58.4, SD 12.4; range 22–83 years Sex: 75.6% men KPS: NR |
|
Tumour characteristics | GBM: 100% First diagnosis: 100% Biopsy: 0%; subtotal resection: 0%; total resection: 100% IDH1 wild‐type: 97.4%; IDH2 wild‐type: NR |
|
Treatment regimen | Concurrent radiotherapy and TMZ followed by adjuvant TMZ (61.5%) or TMZ as an adjuvant therapy after radiotherapy (38.5%) | |
MGMT promoter methylation tests implemented | MSP, PSQ | |
Dates and follow‐up | Timing of MGMT assessment: at diagnosis Start time for follow‐up: NR; follow‐up: median NR; range NR |
|
Notes |